Education:
Dr. Qin received his medical degree from Shanghai Medical University in 1985, and Master’s degree in 1988 from Shanghai Second Medical University. After graduation, he became a vascular surgery attending in Renji University Hospital, Shanghai.
In 1995, he has pursued his Postdoctoral cardiovascular research in Yale University School of Medicine. Dr. Qin completed his fellowship in vascular surgery at Northwell Healthcare in 2009. He practiced vascular surgery since then in New York till 2022.
Dr. Qin has over 30 years of clinical experience. Before joining Jiahui International Hospital, Dr. Qin served as an attending vascular surgeon in Lenox Hill Hospital and Mount Sinai Hospital in New York City.
Dr. Qin is board certified by the American Board of Surgery and an active member of the Society of Vascular Surgery (USA). In addition to his clinical work, Dr. Qin has multiple publications in the Journal of Vascular Surgery and numerous awards in vascular societies.

Areas of specialty treatments:
Dr. Qin has extensive clinical experience on full spectrum of vascular diseases, including carotid stenosis, aortic aneurysm, mesenteric ischemia, peripheral vascular occlusion, vascular trauma, dialysis access, varicose vein and vascular malformation, etc.

 Dr. JI Qinghai is currently the specially-invited consultant of General Surgery Department of Jiahui Health. Dr. Ji graduated from Shanghai Medical University in 1983 and received his master's degree in Clinical Medicine from Shanghai Medical University in 1993. He was the Chief of Head & Neck Surgery Department at Fudan University Shanghai Cancer Center, the chief expert and the convenor of the multidisciplinary comprehensive treatment group of Head & Neck Cancer at Fudan University Shanghai Cancer Center. Dr. Ji Qinghai is the vice Chairman of the Thyroid Cancer Committee of the Chinese Anti-Cancer Association, the vice chairman of the thyroid Cancer Committee of the Chinese Medical Doctor Association, the chairman of the Thyroid Cancer Committee of the Shanghai Anti-Cancer Association, and the leader of the Thyroid Science Group of the General Surgery Committee of the Shanghai Medical Association. Member of Standing Committee of Head & Neck Tumor Professional Committee of China Anti-Cancer Association and former chairman of Head & Neck Tumor Professional Committee of Shanghai Anti-Cancer Association.

He is the editoiral board member of Chinese Journal of Otolaryngology -- Head & Neck Surgery, Chinese Journal of Surgery, Chinese Journal of Cancer, Journal of Chinese Academy of Medical Sciences, Cancer, Chinese Journal of Cancer, Chinese Medical Journal, Medicine, World Journal of Surgical Oncology, Oncotargets and Therapy.

Dr. Ji has been engaged in head & neck cancer surgery for more than 30 years, focusing on clinical and basic research in the treatment of thyroid, laryngeal, hypopharyngeal and tongue cancers. "Surgical treatment of thyroid cancer invading piriform fossa" won the Clinical Achievement Award of Fudan University. Professor Ji Qinghai has presided over a number of major projects of Shanghai Science and Technology Commission, major basic research projects of Shanghai and top priority projects of Shanghai. He has led the research direction of papillary thyroid cancer in China and committed himself to the formulation of diagnosis and treatment standards for papillary thyroid cancer and the standardized training of thyroid surgeons. Since 2015, he has gone throughout the country to promote the standardization of diagnosis and treatment of thyroid cancer, and the specialization of thyroid surgeon training in China.

Areas of expertise:
Diagnosis and surgical treatment of head & neck tumors, including thyroid, salivary glands, oral tumors and laryngeal and laryngeal cancers.

Areas of expertise
hepatopancreatobiliary surgery, gastrointestinal surgery

Dr. HUANG Yangqing graduated from the Naval Medical University with a Doctor's degree in Clinical medicine. He has worked in the Dongfang Hepatobiliary Surgery Hospital of Naval Medical University for nearly 20 years. He is now the Chief of Service (COS) and chief physician of the Hepatobiliary Surgery Department of Shanghai Public Health Clinical Center, and the master's supervisor of Fudan University. In 2017, he was awarded the first "Top Ten Outstanding Doctors" by Fudan University Medical School (formerly Shanghai Medical College).

The diseases and surgical procedures that Dr Wong specializes in including but not limited to:

• Diagnosis of liver cancer and other benign and malignant liver diseases, including primary liver cancer, metastatic liver cancer (such as liver metastasis of bowel cancer), hepatic hemangioma, hepatic cysts, focal nodular hyperplasia of liver, and surgical treatment including laparoscopic hepatectomy, minimally invasive surgery represented by radiofrequency or microwave ablation of liver tumors, and open hepatectomy
• Benign and malignant diseases of the biliary tract, including the diagnosis of gallstones, cholangiolithiasis, gallbladder cancer, cholangiocarcinoma, performing laparoscopic cholecystectomy, cholangiocarcinectomy, choledocholithotomy and other minimally invasive and open operations
• Diagnosis of benign and malignant diseases of pancreas, including pancreatic cancer, pancreatic calculus, pancreatic cyst, pancreatic IPMN and other diseases, performing minimally invasive or open laparoscopic surgery
• Portal hypertension splenomegaly hypersplenism, comprehensive treatment with minimally invasive laparoscopic splenectomy
• Gastrointestinal benign and malignant diseases, including the diagnosis of gastric and intestinal cancer, minimally invasive laparoscopic and open surgery;
• Conservative treatment of hepatobiliary, pancreatic and gastrointestinal malignancies, including tumor chemotherapy, targeted and immunotherapy, external biliary drainage to relieve biliary obstruction, supportive treatment of tumor patients, etc.

Dr. ZHANG Jiwei is is currently the specially-invited consultant of General Surgery Department of Jiahui Health. He is the former Executive Director of Vascular Surgery, Chief Surgeon, master tutor, Renji Hospital Shanghai Jiaotong University School of Medicine. He is a member and consultant of Vascular Surgery Group, Surgery Society of Chinese Medical Association; Vice Chairman of the Professional Committee of Peripheral Vascular Disease, Chinese Association of Integrated Traditional and Western Medicine; Standing member and consultant of Vascular Surgeons Committee, Surgeons Branch of Chinese Medical Doctor Association; Consultant of the National Committee of Cardiovascular Specialists Vascular Surgery Specialty Committee.

He won the third prize of Science and Technology Progress of the Ministry of Health and the State Education Commission, the second prize of Science and Technology Progress of Shanghai and the third prize of Medical Science and Technology of Shanghai. He studied Vascular Surgery at Yamagata University School of Medicine in Japan, HARTFORD Hospital in the United States and LEIPZIG Cardiovascular Center in Germany. He has supervised more than 20 master's students in Vascular Surgery and assisted 10 doctoral students. He is the editorial board member and review expert of 6 journals, including Chinese Journal of Surgery, Chinese Journal of Practical Surgery, Chinese Journal of Radiological Intervention and Chinese Journal of Vascular Surgery.

With nearly 40 years of surgical experience, Dr. Zhang has successfully implemented tens of thousands of vascular open surgery and vascular interventional therapy. He mainly focuses on abdominal aortic, visceral, limb aneurysms, inferior vena cava and posterior peritoneal tumors, carotid and peripheral atherosclerotic stenosis and occlusion, vasculitis, diabetic foot, lower limb varicose veins, chronic limb ulcers, deep vein thrombosis, complex vascular malformations and minimally invasive treatment, as well as chronic renal insufficiency arteriovenous fistula establishment and obstruction rereconstruction surgery.

Chief physician, professor, doctoral supervisor of Huashan Hospital, Fudan University. He has carried out clinical, scientific research and teaching work in Surgery for more than 30 years, and established and developed minimally invasive surgery and obesity hernia surgery in Huashan Hospital. He has presided over a number of national research funds, published more than 80 papers, and obtained more than 10 national patents.

Dr. Yao’s main practices include but are not limited to the following conditions:
· Minimally invasive treatment and multidisciplinary collaborative management of obesity and obesity-induced metabolic diseases such as type 2 diabetes mellitus, hypertension, hyperlipidemia, sleep apnea syndrome, polycystic ovarian syndrome. Repair surgery for abdominal wall and limbs skin relaxation after weight gain and weight loss. Originally created NissanPlus technology for the treatment of obesity.
· Minimally invasive treatment and functional reconstruction for parastostomy hernia, postpartum rectus separation, incisional hernia, umbilical hernia, abdominal wall hernia and inguinal hernia. Originally created the Lap-re-Do technology to treat parastomal hernia and LAMP to repair inguinal hernia.
· Minimally invasive treatment of gastroesophageal reflux disease (GERD) and hiatal hernia.

Deputy chief physician of the Department of Pancreatic Surgery, Ruijin Hospital, leader of the treatment group of the 1st ward of Pancreatic Surgery.
Foreign resident of Hepatobiliary Center in Paul Brousse Hospital, Paris, France.
Visiting scholar of Gastrointestinal Cancer Research Center, Civil Hospital, Strasbourg, France.
Visiting scholar of Hopkins Pancreatic Center, USA.

Dr. Jin’s main practices include but are not limited to the following conditions:
Diagnosis and treatment of pancreatic benign and malignant tumors, including open and minimally invasive surgery (laparoscopic surgery / robotic surgery).

Dr. LI Dong graduated from the seven-year program at China Medical University with a Master's degree. Afterwards she moved to Japan and holds a Japanese medical license. She completed her residency at Obihiro Hospital in Hokkaido, Japan, and subsequently joined the breast surgery department at Hokkaido University Hospital in April 2020. Dr. Li has extensive experience in breast surgery and general surgery at both Hokkaido University Hospital and its affiliated hospitals. She achieved Board Certified Surgeon status in Japan in September 2023.

Dr. Li specializes in various surgical procedures, including:
- Laparoscopic inguinal hernia repair, laparoscopic appendectomy, laparoscopic cholecystectomy.
- Diagnosis and treatment of breast cancer, including breast tumor biopsy, sentinel lymph node biopsy (SLNB), axillary excision, mastectomy, and breast-conserving treatment
- Breast cancer endocrine therapy and chemotherapy, as well as the comprehensive management

License NO. : 110211422000384

Dr. WANG Wei is currently the specially-invited consultant of General Surgery Department of Jiahui Health. As a Chief Physician in Fudan University Shanghai Cancer Center, he has also the following positions.

Executive Deputy Director, Shanghai Institute of Pancreatic Cancer
Executive Deputy Director, Pancreatic Cancer Institute, Fudan University
Deputy Director, Institute of Biliary Diseases, Fudan University
Deputy Director, Institute of Pancreatic Diseases, Fudan University
Co-chairman of the Hepatobiliary Surgery Expert Committee of the National Telemedicine and Internet Medicine Center
Member of Pancreatic Surgery Group, Surgical Society of Chinese Medical Association
Standing member of Pancreatic Cancer Professional Committee of Chinese Anti-Cancer Association, head of Minimally Invasive Diagnosis and Treatment Group
Member of Chinese Medical Doctor Association Biliary Surgery Expert Working Group, Robot Surgery Expert Working Group
American College of Surgeons Fellow (FACS)
Deputy Director, Shanghai Anti-Cancer Association Pancreatic Cancer Committee

Dr. Wang's areas of expertise are: Diagnosis and treatment of benign and malignant pancreatic diseases: pancreatic cancer, benign pancreatic space occupation, pancreatic endocrine tumors such as islet cell tumor, acute and chronic pancreatitis, etc
He is specialized at laparoscopic pancreaticoduodenectomy, laparoscopic middle pancreatectomy, laparoscopic pancreaticocaudectomy, etc

Current Appointment: General Surgery consultant in Jia Hui Healthcare

Clinical Experience
Dr Feng Bo is an experienced General Surgery with more than 18 years of clinical experience. He is currently Chief Physician of General Surgery at Rui Jin Hospital affiliated to Shanghai Jiao Tong University.

Specialty
Dr Feng Bo is skilled in the diagnosis and comprehensive treatment of benign and malignant colorectal disease. He is very experienced in minimal invasive surgery, including Laparoscopy for colorectal cancer, gastric cancer, anus preserving surgery for low rectal cancer, da Vinci robotic surgery, hernia, thyroid Minimally invasive procedure, and colonoscopy for colorectal cancer.

Academic Achievement
- Member of the Chinese Medical Association
- Member of the Colorectal Surgery Group, Chinese Medical Association Surgeons Branch
- Vice Chairman of the TATME Professional Committee of the Surgeon Branch of the Chinese Medical Doctor Association
- Vice Chairman of the Colorectal and Anorectal Surgery Committee of the Chinese Research Hospital Association
- Vice Chairman of Minimally Invasive Anatomy Group of Colorectal Cancer Physicians Committee of Chinese Medical Doctor Association
- Vice Chairman of Youth Committee of Colorectal Cancer Physicians Committee of Chinese Medical Doctor Association
- Vice Chairman of MDT Young Physicians Committee of Surgeon Branch of Chinese Medical Doctor Association
- Vice Chairman of the Colorectal and Anorectal Functional Surgery Branch of the Chinese Sexuality Society
- Member of the Specialized Committee on Capacity Building and Continuing Education Surgery of the National Health Commission
- Member of Colorectal Surgeon Committee of Surgeon Branch of Chinese Medical Doctor Association
- Member of Anorectal Surgeon Committee of Surgeon Branch of Chinese Medical Doctor Association

Awards and honors
- First Prize for Science and Technology Progress of the Ministry of Education
- First Prize of Shanghai Science and Technology Progress Award
- First Prize of Shanghai Medical Science and Technology Award
- Second Prize of the Chinese Medical Award
- Shanghai Jiao Tong University Kowloon Award

Dr. Li Qinyu is the associate Professor, Doctor of Medicine, Deputy Chief Physician of General Surgery, Ruijin Hospital Shanghai Jiaotong University School of Medicine, part-time doctor of General surgery of Jiahui Health.

From 2003 to 2004, he visited the Queen Mary Hospital of the University of Hong Kong. In 2016 and 2017, he visited Yonsei University in South Korea and Johns Hopkins University in the United States for exchange studies.

He has been engaged in the diagnosis and surgical treatment of thyroid diseases, focusing on the specialized application of minimally invasive technology (endoscopy, robotic system, ablation technology). Specializes in all kinds of benign and malignant thyroid and parathyroid disease precision surgery, including giant thyroid tumor, hyperthyroidism, retrosternal thyroid tumor surgery, recurrent thyroid surgery and neck lymph node dissection. He specializes in the application of minimally invasive neck surgery techniques, including minimally invasive thyroid and parathyroid surgeries such as axillary approach, breast approach, transoral approach, and Miccoli surgery with small incision in neck. He is good at functional protection (nerve, parathyroid exposure protection and functional neck lymph node dissection). He has published more than 20 papers in scientific journals, including 6 SCI papers, and participated in the preparation of 2 monographs. He has led and participated in a number of national and Shanghai Science and Technology Commission and Health Bureau projects.

Areas of expertise:
Thyroid surgery, gastrointestinal tumor surgery and robotic, endoscopic minimally invasive surgery techniques
(Thyroid, parathyroid benign and malignant tumors surgery and endoscopic minimally invasive technology, radiofrequency ablation technology application)